Porzio Life Sciences - an RLDatix Company

RLDatix Life Sciences announces the integration of Porzio Life Sciences - an RLDatix Company, iContracts - an RLDatix Company, and iCoachFirst. This strategic union – a business unit of RLDatix, the leading global provider of connected healthcare operations software and services – marks the launch of a new business poised to lead innovation and drive excellence in the life sciences sector. Read more here: https://lnkd.in/dkD2G7m7

Stop by Booth #204 to speak with our experts and learn more about how RLDatix Life Sciences leads the charge in empowering world-class organizations to master complexity, mitigate risk, and soar beyond the standards of compliance and efficiency.

We are excited to announce that we will be at the 25th Annual Pharma Congress from October 28 to 30, 2024! Join us in Washington, D.C., where our experts, including Audrey DeGuarde, Nancy Henshaw, and John Oroho, will share key insights on compliance and regulatory trends. You should also be sure to stop by our booth and learn more about our strategic integration with iContracts - an RLDatix Company and iCoachFirst - an RLDatix Company.

RLDatix Life Sciences is a proud sponsor of this year's Informa Connect Life Sciences #MDRPSummit, which will take place September 23-25, 2024. The summit, which will be held at the Chicago Marriott Downtown Magnificent Mile, features an agenda packed with sessions discussing the challenges in #drugpricing pressure and #healthpolicy that will profoundly impact our industry.     Our own Sarah E. McClure, VP of Knowledge Management, and Katie Johnson, Director of Federal Compliance Services, will co-present on a panel during Day One of the event - 'Practical Strategies for Emerging, Small, and Mid-Size Companies.' You won't want to miss it! There's still time to register! Visit https://lnkd.in/eB-mqhvW and use the code 24RLDATIX10 to receive 10% off!

Looking forward to seeing everyone next week in Toronto at #PCCCanada!

We are thrilled to announce that Shane White will be the Chairperson for the 3rd Annual Dynamic Global Events (DGE) Transparency and Aggregate Spend Conference next week in Philadelphia, PA. RLDatix Life Sciences is proud to sponsor the event, and we look forward to seeing many of you there! Stop by our booth to see how we work to #RedefineRisk and #OptimizeOutcomes for our customers. There's still time to register! Be sure to use our exclusive code "Sponsor290" for 15% off!

🎉 Exciting News! Registration is now OPEN for RLDatix Life Sciences Palooza! 🚀 Join us for two and a half days of learning, networking, and innovation in the life sciences compliance and regulatory technology space. 📅 Date: October 8-10, 2024📍 Location: Hard Rock Hotel, Atlantic City, NJ 🔗 Register now at https://lnkd.in/eS43Ghnq  and secure your spot! #RLDatixLifeSciences

📢 BREAKING NEWS out of #Virgina! VA Extends Reporting Deadline to May 1, 2024  Emergency regulations governing the Virginia #prescription #drugpricingtransparency program lapsed on January 15, 2024. The 2024 General Assembly passed House Bill 592, extending the emergency regulations governing this program. If signed by the Governor, House Bill 592 will provide for maintaining the emergency rules retroactively from January 15, 2024, until Final Regulations are adopted and implemented. Virginia Health Information extended the reporting deadline from April 1, 2024, to May 1, 2024, as the Governor has not yet signed the legislation. All data reporting entities must submit reporting requirements or a no data attestation for the 2023 reporting period by May 1, 2024. As professionals in the #LifeSciences industry, staying informed and engaged with developments like these is imperative as they shape the landscape in which we operate. Sign up for your free trial of our #ComplianceDigest to stay in the know: https://lnkd.in/eweHs_qk

Breaking News out of #NewMexico and #Connecticut! 📢 🔴 New Mexico State Drug Reporting Law - On March 1st, the Governor of New Mexico signed House Bill 33, which will become effective on January 1, 2025. This Law establishes the Prescription Drug Price Transparency Act by amending the New Mexico Insurance Code. 🔴 Connecticut Marketing Firm Annual Reporting Form—The Connecticut Department of Consumer Protection has released the Marketing Firm Annual Reporting Form. Manufacturers that employ pharmaceutical sales representatives must register with the Department annually as a pharmaceutical marketing firm. Registration expires annually on June 30th. As professionals in the Life Sciences industry, staying informed and engaged with developments like these is imperative as they shape the landscape in which we operate. Sign up for your free trial of our #ComplianceDigest to stay in the know: https://lnkd.in/eweHs_qk

Breaking News! 📢 On February 16, 2024, a significant ruling was made by the United States District Court for Oregon regarding the Prescription Drug Price Transparency Act. The Court declared that ORS 646A.689(3) has been found to infringe upon the First Amendment, rendering it unenforceable. This decision highlights the crucial intersection of legal frameworks and public health policies. It underscores the importance of balancing regulatory measures with constitutional rights, particularly in the realm of healthcare accessibility and transparency. As professionals in the Life Sciences industry, staying informed and engaged with developments like these is imperative as they shape the landscape in which we operate. Sign up for your free trial of our #ComplianceDigest to stay in the know: https://lnkd.in/eweHs_qk